Drug manufacturers Eli Lilly and Sanofi late yesterday asked federal judges for temporary protection from federal health agency orders to immediately resume offering 340B pricing on drugs shipped to contract pharmacies. Drug maker Novo Nordisk is expected to seek similar judicial protection. Government lawyers will oppose most of these moves.
AstraZeneca on Wednesday asked a federal judge “for a short administrative stay to temporarily preserve the status quo” in its lawsuit over the government’s efforts to compel it to resume 340B pricing on drugs dispensed by contract pharmacies, or to issue an expedited final ruling. The judge could rule on AstraZeneca’s motion as soon as this evening.
Drug manufacturers Eli Lilly and Sanofi late yesterday asked federal judges for temporary protection from federal health agency orders to immediately resume offering 340B pricing on drugs shipped to contract pharmacies. Drug maker Novo Nordisk is expected to seek similar judicial protection. Government lawyers will oppose most of these moves.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
